HL7 FHIR® Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment)

This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.1.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions

Value Sets defined as part of this Implementation Guide

Name Definition
AnatomicalDirectionVS Anatomical location or specimen further detailing directionality. Codes are from NCI
AnatomicalLocationVS Codes that describe normal and pathologic anatomic systems, regions, cavities, and spaces.
BreastCancerDetectionVS Basis for cancer detection, from HL7 CDA® R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm Standard for Trial Use Release 3, October 2016, Volume 2 — Templates and Supporting Material.
BreastCancerStageVS Codes representing the overall stage of the cancer, based on criteria defined by the staging system being used. The preferred staging system is American Joint Committee on Cancer, 8th Edition, Breast Cancer Chapter. Codes and descriptions have been redacted due to copyright restrictions.
BreastCancerTypeVS Histologic types of breast cancer. Codes are drawn from ICD-O-3. Codes are presented as local codes due to the lack of a ICD-O-3 terminology server available to the FHIR IG publisher.
BreastSiteVS Topography of the breast. Codes are drawn from ICD-O-3. Codes are presented as local codes due to the lack of a ICD-O-3 terminology server available to the FHIR IG publisher.
BreastSpecimenCollectionMethodVS The surgical method used to obtain the tissue sample.
BreastSpecimenTypeVS The type of specimen obtained from the breast.
ClockDirectionVS The relative direction of an object described using the analogy of a 12-hour clock to describe angles and directions. One imagines a clock face lying either upright or flat in front of oneself, and identifies the twelve hour markings with the directions in which they point.
DeltaFlagVS Indicators for degree of change (delta) from the last or previous measurement.
DiagnosticServiceVS The type of laboratory service used in producing a laboratory result
ExceptionValueVS Reasons that a value associated with a test or other finding is missing. Extended set based on http://hl7.org/fhir/ValueSet/observation-valueabsentreason
HER2IHCMethodVS Value set containing methods of determining HER2 status by immunohistochemistry
HER2ISHMethodVS Value set containing In Situ Hybridization methods of determining HER2 status
HER2StatusVS HER2 status overall result
HER2byIHCScoreVS Value set containing possible scores resulting from determining HER2 status by immunohistochemistry. Based on LNC#LL4396-9 answer list.
MammaprintRiskScoreInterpretationVS Intepretation of Mammaprint Recurrence Score
MitoticCountScoreVS Value set containing the scores for Nottingham Histologic Score Mitotic Rate
MorphologyBehaviorVS The morphologic behavior of the cancer. These are the suffix to the ICD-O-3 histologic type codes. Codes are presented as local codes due to the lack of a ICD-O-3 terminology server available to the FHIR IG publisher.
NottinghamCombinedGradeVS Combined score from the Nottingham grading system.
NuclearGradeVS The nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells. In general, the higher the nuclear grade, the more abnormal the nuclei are and the more aggressive the tumor cells tend to be. The nuclear grade is a part of overall tumor grade.
NuclearPleomorphismScoreVS Value set containing the scores for nuclear pleomorphism.
OncotypeDxDCISRiskScoreInterpretationVS Intepretation of OncotypeDX DCIS (Ductal Carcinoma In Situ) Recurrence Score
OncotypeDxInvasiveRiskScoreInterpretationVS Intepretation of OncotypeDX Recurrence Score for invasive cancers.
PositiveNegativeEquivocalVS Interpretation of a test result as positive, negative or equivocal.
PositiveNegativeVS Value set containing the values positive and negative. Values are from National Library of Medicine Metathesaurus.
PresenceContextVS A code describing whether the finding in question is present, possible, suspected, etc.
RecurrenceRiskScoreInterpretationVS Interpretations of risk as high, intermediate, or low. Answer set taken from LOINC LL3198-0
StageTimingPrefixVS When staging was done, relative to treatment events.
StagingMethodVS The methodology or standard used to assign the cancer's overall stage.
StainingIntensityVS Part of the Allred scoring, based on the intensity of that staining, on a scale of 0 (Negative) to 3 (Strong).
TubuleFormationScoreVS Value set containing the extent (scope) of tubule formation.
YesNoUnknownVS A simple value set containing the values Yes (or true), No (or false), and Unknown